These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4385975)

  • 21. Addendum on serum levels.
    Begg KJ
    Tubercle; 1967 Jun; 48(2):149-50. PubMed ID: 6048657
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary drug resistance of mycobacteria tuberculosis in Taiwan.
    Wu YT
    Taiwan Yi Xue Hui Za Zhi; 1973 Mar; 72(3):135-42. PubMed ID: 4634133
    [No Abstract]   [Full Text] [Related]  

  • 24. Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing.
    Raleigh JW; Wichelhausen R
    Am Rev Respir Dis; 1973 Sep; 108(3):639-42. PubMed ID: 4200815
    [No Abstract]   [Full Text] [Related]  

  • 25. Microbiology of cutaneous tuberculosis.
    Sharma RC; Singh R; Bhatia VN
    Tubercle; 1975 Dec; 56(4):324-8. PubMed ID: 59443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 27. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
    Cohn ML; Davis CL
    Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
    [No Abstract]   [Full Text] [Related]  

  • 28. [Correlation between the catalase activity and resistance to drugs in Mycobacterium tuberculosis circulating in Southeast Africa].
    Zykov MP
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):49-53. PubMed ID: 4295172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)].
    Golyshevskaia VI; El'shanskaia MP
    Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technical and bacteriological aspects of a continuous survey of drug resistance in tuberculosis in South Africa.
    De ville de Goyet CA; Kleeberg HH
    Tubercle; 1972 Mar; 53(1):9-26. PubMed ID: 4114098
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative determinations of Mycobacterium resistance using the vertical diffusion test and the proportion method (economical test)].
    Kalich R; Nitschke M; Ulber H; Mydlak G; Werner E; Gerloff W; Reinhold L
    Z Erkr Atmungsorgane; 1974; 140(3):242-52. PubMed ID: 4142152
    [No Abstract]   [Full Text] [Related]  

  • 32. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
    Tousek J; Jancik E; Zelenka M; Jancikova-Máková M
    Tubercle; 1967 Mar; 48(1):27-31. PubMed ID: 4291925
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL; Johnson PM; Boytar-Papirnyik V; Wilber J
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 35. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1971 Jun; 103(6):842-4. PubMed ID: 4996847
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 39. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. I. Incubating temperature and chemotherapeutic effect].
    Maekawa N; Nakanishi M; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Jul; 46(7):235-7. PubMed ID: 5000367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.